May/June 2017—NONVIRAL GENE THERAPY FOR UVEITIS BEGINS CLINICAL TRIAL
A nonviral gene therapy, said to be the first of its kind, is being evaluated in a phase 1/2 clinical trial in patie…
Davide Allegrini, MD; Alfredo Pece, MD; Giovanni Montesano, MD; Claudia Tarlarini, MD; Paola Primignani, MD; Elena Piozzi, MD; Luisa Grassi, MD; Luca Rossetti, MD; and Silvana Penco, MD
May/June 2017—A close look at a small group of patients helped devise a new approach to managing patients with this rare syndrome.
Alexis Warren, BS; R. Joel Welch, MD; and Carol L. Shields, MD
March 2017—Lesions that mimic choroidal melanoma may actually belong to a spectrum of peripheral neovasculopathy.
Michael Owyong, BS; Stephen G. Schwartz, MD, MBA; and Ingrid U. Scott, MD, MPH
March 2017—Many studies have found statistically significant associations between genetic polymorphisms and DR, but other studies have found no associations.
March 2017—LONGER-TERM DME OUTCOMES PREDICTED BY EARLY RESPONSE TO ANTI-VEGF THERAPY
Eyes with diabetic macular edema (DME) that have an early response to anti-VEGF treatment, measure…
Manish Nagpal, MS, DO, FRCS(Edin), and Shishir Shekhar Singh, MS
November/December 2016—A case series demonstrates the value of this new imaging modality.
Michael D. Tibbetts, MD; edited by Heeral R. Shah, MD, and Jordana G. Fein, MD
November/December 2016—In this case report, multimodal imaging in an older patient with an atypical presentation of inflammatory chorioretinopathy provided useful information.
Stephen G. Schwartz, MD, MBA, and Ingrid U. Scott, MD, MPH
November/December 2016—Results from the DRCR.net’s Protocols S and T lend insights on the management of these conditions in clinical practice.
